Search results for "Pandemic"

showing 10 items of 1097 documents

Does the use of face masks during the COVID-19 pandemic impact on oral hygiene habits, oral conditions, reasons to seek dental care and esthetic conc…

2021

Background To evaluate the impact of the use of face masks on oral hygiene habits; oral conditions self-perception; reasons to seek dental treatment; and esthetic concerns. Material and methods 1346 participants answered a web-based survey with questions related to the aims of the study. Descriptive statistic was performed and the responses were analyzed with chi-square test and regression analysis. Results With the use of masks, toothbrushing frequency decreased significantly, and people are significantly less concerned about oral hygiene. The number of subjects that reported to have halitosis increased significantly and this was associated with a decrease in toothbrushing frequency. The g…

medicine.medical_specialtyCOMPORTAMENTOCoronavirus disease 2019 (COVID-19)Descriptive statisticsbusiness.industryResearchDental health030206 dentistryDental careOral hygieneCommunity and Preventive DentistryTest (assessment)Face masksstomatognathic diseases03 medical and health sciences0302 clinical medicineFamily medicinePandemicMedicinebusinessGeneral DentistryUNESCO:CIENCIAS MÉDICAS030217 neurology & neurosurgery
researchProduct

Appendectomy during the COVID-19 pandemic in Italy: a multicenter ambispective cohort study by the Italian Society of Endoscopic Surgery and new tech…

2021

AbstractMajor surgical societies advised using non-operative management of appendicitis and suggested against laparoscopy during the COVID-19 pandemic. The hypothesis is that a significant reduction in the number of emergent appendectomies was observed during the pandemic, restricted to complex cases. The study aimed to analyse emergent surgical appendectomies during pandemic on a national basis and compare it to the same period of the previous year. This is a multicentre, retrospective, observational study investigating the outcomes of patients undergoing emergent appendectomy in March–April 2019 vs March–April 2020. The primary outcome was the number of appendectomies performed, classifie…

medicine.medical_specialtyCOVID-19 PandemicCoronavirus disease 2019 (COVID-19)Endoscopic surgeryNOAppendectomy; Appendicitis; COVID-19 Pandemic; Machine learningCohort Studies03 medical and health sciences0302 clinical medicinePostoperative ComplicationsRetrospective StudiePandemicMachine learningmedicineHumansAppendectomyAppendicitiLaparoscopyPandemicsRetrospective Studiesmedicine.diagnostic_testPandemicbusiness.industryCOVID-19 Pandemic Appendicitis Appendicectomy Machine learningSARS-CoV-2COVID-19Length of Staymedicine.diseaseAppendicitisAppendicitisSettore MED/18SurgeryItaly030220 oncology & carcinogenesisAppendectomy; appendicitis; COVID-19 pandemic; machine learning; appendectomy; cohort studies; humans; Italy; length of stay; pandemics; postoperative complications; retrospective studies; SARS-CoV-2; appendicitis; COVID-19; laparoscopy030211 gastroenterology & hepatologySurgeryObservational studyOriginal ArticleLaparoscopyPostoperative ComplicationAppendicectomyCohort StudiebusinessComplicationCohort studyHuman
researchProduct

Management of patients with Intestinal Bowel Disease and COVID-19: A review of current evidence and future perspectives

2022

La pandemia por COVID-19 ha supuesto un reto para los países y sus profesionales sanitarios. La entrada viral en el hospedador a través del receptor ACE-2 y una activación excesiva del sistema inmunológico son claves para comprender tanto la incidencia como la gravedad de la enfermedad. La enfermedad inflamatoria intestinal (EII) representa una condición especial asociada con una respuesta descontrolada del sistema inmunológico a agentes externos. Los tratamientos para la EII se han asociado con un mayor riesgo de infecciones bacterianas y virales. Esto ha planteado la cuestión de una posible mayor incidencia y gravedad de la infección por COVID-19 en pacientes con EII. A lo largo de este a…

medicine.medical_specialtyCOVID-19 VaccinesIBD-treatmentCOVID-19 VaccinePopulationDiseaseIncidencia por COVID-19COVID-19 graveInflammatory bowel diseaseSulfasalazineInternal medicinetratamiento de la EIIPandemicmedicineHumansEnfermedad Inflamatoria Intestina (EII)Inflammatory Bowel Disease (IBD)educationSevere COVID-19Pandemicseducation.field_of_studyTofacitinibHepatologybusiness.industryVacuna COVID-19Incidence (epidemiology)GastroenterologyRevisadoCOVID-19General Medicinemedicine.diseaseInflammatory Bowel DiseasesVaccinationCOVID-19 incidenceTumor Necrosis Factor Inhibitorsbusinessmedicine.drugGastroenterología y Hepatología (English Edition)
researchProduct

An Insight into the Role of Postmortem Immunohistochemistry in the Comprehension of the Inflammatory Pathophysiology of COVID-19 Disease and Vaccine-…

2021

On 11 March 2020, the World Health Organization (WHO) declared a pandemic due to the spread of COVID-19 from Wuhan, China, causing high mortality rates all over the world. The related disease, which mainly affects the lungs, is responsible for the onset of Diffuse Alveolar Damage (DAD) and a hypercoagulability state, frequently leading to Severe Acute Respiratory Syndrome (SARS) and multiorgan failure, particularly in old and severe-critically ill patients. In order to find effective therapeutic strategies, many efforts have been made aiming to shed light on the pathophysiology of COVID-19 disease. Moreover, following the late advent of vaccination campaigns, the need for the comprehension …

medicine.medical_specialtyCOVID-19 VaccinesQH301-705.5AutopsyReviewDiseaseCatalysisInorganic ChemistryvaccinePandemicHumansMedicineEndotheliumBiology (General)Physical and Theoretical ChemistryIntensive care medicineDiffuse alveolar damageAdverse effectQD1-999Molecular BiologypathophysiologySpectroscopypostmortemChAdOx1 nCov-19SARS-CoV-2business.industryMechanism (biology)Organic ChemistryCOVID-19ThrombosisGeneral MedicinePathophysiologyComputer Science ApplicationsVaccinationChemistryimmunohistochemistryCytokinesAutopsybusinessInternational Journal of Molecular Sciences
researchProduct

SARS-CoV-2 vs. Hepatitis Virus Infection Risk in the Hemodialysis Population: What Should We Expect?

2021

Since the dramatic rise of the coronavirus infection disease 2019 (COVID-19) pandemic, patients receiving dialysis have emerged as especially susceptible to this infection because of their impaired immunologic state, chronic inflammation and the high incidence of comorbidities. Although several strategies have thus been implemented to minimize the risk of transmission and acquisition in this population worldwide, the reported severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence varies across studies but is higher than in the general population. On the contrary, the screening for hepatitis viruses (HBV and HCV) has seen significant improvements in recent years, with va…

medicine.medical_specialtyCOVID19Health Toxicology and Mutagenesismedicine.medical_treatmentPopulation030232 urology & nephrologymedicine.disease_cause03 medical and health sciences0302 clinical medicineRenal DialysisSeroepidemiologic StudiesPandemicHepatitis VirusesmedicineSeroprevalenceHumanshepatitisIntensive care medicineeducationCoronavirusHepatitiseducation.field_of_studybusiness.industryTransmission (medicine)SARS-CoV-2RPublic Health Environmental and Occupational Healthvirus diseasesCOVID-19medicine.diseaseVaccinationEditorialMedicinedialysis030211 gastroenterology & hepatologyHemodialysisbusinesschronic kidney diseaseInternational Journal of Environmental Research and Public Health
researchProduct

Accurate Triage of Oncological Patients for Safely Continuing Cancer Therapy During the SARS-CoV-2 Pandemic

2021

ObjectiveTo evaluate the efficacy of clinical triage of oncological patients for safe continuation of cancer therapy implemented during the first SARS-CoV-2 outbreak.MethodsBetween 25 February and 21 April 2020, patients attending the Medical Oncology Unit, Spedali Civili Hospital, Brescia (Italy) for cancer therapy underwent triage to identify those with no signs and symptoms suspicious for SARS-CoV-2 infection in which antineoplastic treatment could be continued as scheduled. Triage questions investigated common symptoms (e.g., fever, cough, dyspnea, anosmia, dysgeusia, headache, nasal congestion, conjunctival congestion, sore throat, diarrhea, nausea and vomiting); body temperature and p…

medicine.medical_specialtyCancer Researchbusiness.industryNauseapandemicAnosmiaCancerNeoplasms. Tumors. Oncology. Including cancer and carcinogensCOVID-19SARS-COV-2Nasal congestionmedicine.diseaseTriageanticancer therapy; COVID-19; oncology; pandemic; SARS-COV-2DysgeusiaOncologyInternal medicinemedicineSore throatVomitinganticancer therapymedicine.symptombusinessRC254-282Original ResearchFrontiers in Oncology
researchProduct

A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19

2020

Purpose COVID-19 (coronavirus disease 2019) is a public health emergency of international concern. As of this time, there is no known effective pharmaceutical treatment, although it is much needed for patient contracting the severe form of the disease. The aim of this systematic review was to summarize the evidence regarding chloroquine for the treatment of COVID-19. Methods PubMed, EMBASE, and three trial Registries were searched for studies on the use of chloroquine in patients with COVID-19. Results We included six articles (one narrative letter, one in-vitro study, one editorial, expert consensus paper, two national guideline documents) and 23 ongoing clinical trials in China. Chloroqui…

medicine.medical_specialtyChinaCoronaviruPneumonia ViralPsychological interventionMEDLINEDiseaseCritical Care and Intensive Care MedicineWorld Health OrganizationArticle03 medical and health sciencesAntimalarialsBetacoronavirus0302 clinical medicineChloroquinePandemicmedicineHumansIntensive care medicinePandemicsClinical Trials as Topicbusiness.industrySARS-CoV-2Public healthCOVID-19030208 emergency & critical care medicineChloroquinePneumoniaCOVID-19 Drug TreatmentClinical trialCoronavirusClinical researchTreatment Outcome030228 respiratory systembusinessCoronavirus Infectionsmedicine.drugJournal of Critical Care
researchProduct

SARS-CoV-2 and the Risk Assessment Document in Italian Work: Specific or Generic Risk Even If Aggravated?

2021

In December 2019, several cases of atypical pneumonia were detected in Wuhan city, Hubei province, inland China. The initial outbreak was of considerable size first in China subsequently spread to the rest of the world. Immediately after the epidemic (which according to the World Health Organization had risen to pandemic status), the problem of whether or not to update the occupational risk assessment arose, also considering how the biological risk from SARS CoV-2 should be understood: specific or generic. To this end, we conducted a literature review to identify national health legislation and policies, examining how Italy has addressed the COVID-19 emergency in occupational health plannin…

medicine.medical_specialtyChinaoccupational medicineHealth Toxicology and Mutagenesislcsh:MedicineLegislationReviewSettore MED/42 - Igiene Generale E ApplicataRisk AssessmentOccupational safety and healthOccupational medicine03 medical and health sciences0302 clinical medicineCOVID-19 Decree 81/2008 Law Occupational medicine Prevention and protection measures Risk assessment document Work China Humans Italy Risk Assessment COVID-19 SARS-CoV-2workEnvironmental healthPandemicmedicineHumansprevention and protection measures030212 general & internal medicinelawChina0303 health sciences030306 microbiologySARS-CoV-2lcsh:RPublic Health Environmental and Occupational HealthCOVID-19medicine.diseasedecree 81/2008Work (electrical)Italyrisk assessment documentAtypical pneumoniaBusinessRisk assessment
researchProduct

Hepatitis C: The beginning of the end-key elements for successful European and national strategies to eliminate HCV in Europe

2018

Abstract: Hepatitis C virus (HCV) infection is a major public health problem in the European Union (EU). An estimated 5.6 million Europeans are chronically infected with a wide range of variation in prevalence across European Union countries. Although HCV continues to spread as a largely silent pandemic, its elimination is made possible through the availability of the new antiviral drugs and the implementation of prevention practices. On 17 February 2016, the Hepatitis B & C Public Policy Association held the first EU HCV Policy Summit in Brussels. This summit was an historic event as it was the first high-level conference focusing on the elimination of HCV at the European Union level. The …

medicine.medical_specialtyCivil societyEconomic growthMedizinPublic policyHepacivirusAntiviral AgentsPatient advocacy03 medical and health sciences0302 clinical medicineVirologyPolitical sciencePandemicPrevalencemedicineHumansmedia_common.cataloged_instanceEuropean Union030212 general & internal medicineDisease EradicationEuropean unionmedia_commongeographySummitgeography.geographical_feature_categoryHepatologyPublic healthmedicine.diseaseHepatitis CEuropeInfectious DiseasesHCVEpidemiological Monitoring030211 gastroenterology & hepatologyHuman medicineViral hepatitisJournal of Viral Hepatitis
researchProduct

Recommendations for ophthalmologic practice during the easing of COVID‐19 control measures

2021

Abstract In the context of the COVID‐19 pandemic, this paper provides recommendations for medical eye care during the easing of control measures after lockdown. The guidelines presented are based on a literature review and consensus among all Spanish Ophthalmology Societies regarding protection measures recommended for the ophthalmologic care of patients with or without confirmed COVID‐19 in outpatient, inpatient, emergency and surgery settings. We recommend that all measures be adapted to the circumstances and availability of personal protective equipment at each centre and also highlight the need to periodically update recommendations as we may need to readopt more restrictive measures de…

medicine.medical_specialtyConsensusEye DiseasesCoronavirus disease 2019 (COVID-19)Control (management)Context (language use)Review ArticleEnfermedades infecciosasEye careeye care03 medical and health sciencesCOVID-19 eye care eye health lockdown easing pandemic personal protective equipment0302 clinical medicineCOVID‐19eye healthSalud públicaEpidemiologyPandemicHealth caremedicineHumansPandemicsReview ArticlesPersonal protective equipmentSARS-CoV-2business.industrypandemicCOVID-19General Medicinemedicine.diseaseTelemedicineVirusOphthalmologyAtenció primàriaSpainCommunicable Disease ControlPractice Guidelines as Topiclockdown easingpersonal protective equipment030221 ophthalmology & optometryUlls Malalties i defectesOftalmologíaMedical emergencybusinessUlls030217 neurology & neurosurgery
researchProduct